Market Place
Sourcing Support
Coeptis Presents Poster At ASGCT 27th Annual Meeting
02 May 2024 //
PR NEWSWIRE
Coeptis Therapeutics Expands License Agreement with University of Pittsburgh
11 Oct 2023 //
PR NEWSWIRE
Coeptis Provides Safety & Dosing Update from Phase 1 Trials Investigating DVX201
14 Sep 2023 //
PR NEWSWIRE
Coeptis Announces Pricing of $3.5 Million Underwritten Offering
14 Jun 2023 //
PR NEWSWIRE
Coeptis Therapeutics Engages IQVIA to Support SNAP-CAR Development Program
22 Nov 2022 //
PRNEWSWIRE
Coeptis`s Scientific Advisory Board Members Featured "Biology of(NK) Cells
08 Nov 2022 //
PRNEWSWIRE
Coeptis Therapeutics Holdings Expands Board of Directors with New Appointments
02 Nov 2022 //
PRESS RELEASE
Coeptis Announces Closing of Business Combination with Bull Horn Holdings Corp.
31 Oct 2022 //
PRESS RELEASE
Coeptis Therapeutics Enters Agreement with University of Pittsburgh
21 Sep 2022 //
PRNEWSWIRE
Coeptis Tx Enters into Exclusive Option Agreement with University of Pittsburgh
17 May 2022 //
PRNEWSWIRE
Coeptis Combines with Bull Horn in SPAC Deal to Advance CD38+ Assets
22 Apr 2022 //
BIOSPACE
Coeptis Tx and Bull Horn Holdings Corp. Announce Merger Agreement
19 Apr 2022 //
PRNEWSWIRE
Statera Biopharma, Coeptis Announce Strategic Agreement for Entolimod
13 Apr 2022 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.